Moreover, heterogeneity was also derived from the parameter “methylation gene” as the corresponding coefficient was 0.661 (p = 0.01), which was consistent with the primary outcome of a clinical trial of SEPT9 methylation for CRC detection, indicating SEPT9 as a promising CRC diagnostic biomarker. Here, SEPTIN9 is linked to colorectal carcinoma.